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OBJECTIVE—Exercise is a cornerstone of diabetes management and the prevention of in-
cident diabetes. However, the impact of the mode of exercise on cardiovascular (CV) risk factors
in type 2 diabetes is unclear.
RESEARCH DESIGN AND METHODS—We conducted a systematic review of the lit-
erature between 1970 and October 2009 in representative databases for the effect of aerobic or
resistance exercise training on clinical markers of CV risk, including glycemic control, dyslipi-
demia, blood pressure, and body composition in patients with type 2 diabetes.
RESULTS—Of 645 articles retrieved, 34 met our inclusion criteria; most investigated aerobic
exercise alone, and 10 reported combined exercise training. Aerobic alone or combined with
resistance training (RT) signiﬁcantly improved HbA1c 20.6 and 20.67%, respectively (95% CI
20.98 to 20.27 and 20.93 to 20.40, respectively), systolic blood pressure (SBP) 26.08 and
23.59 mmHg, respectively (95% CI 210.79 to 21.36 and 26.93 to 20.24, respectively), and
triglycerides 20.3 mmol/L (95% CI 20.48 to 20.11 and 20.57 to 20.02, respectively). Waist
circumference was signiﬁcantly improved 23.1 cm (95% CI 210.3 to 21.2) with combined
aerobic and resistance exercise, although fewer studies and more heterogeneity of the responses
were observed in the latter two markers. Resistance exercise alone or combined with any other
form of exercise was not found to have any signiﬁcant effect on CV markers.
CONCLUSIONS—Aerobic exercise alone or combined with RT improves glycemic control,
SBP, triglycerides, and waist circumference. The impact of resistance exercise alone on CV risk
markers in type 2 diabetes remains unclear.
Diabetes Care 34:1228–1237, 2011
D
iabetes is a chronic condition
brought about by the body’s inabil-
ity to produce enough insulin or to
usetheinsulinthatitproduces.Asaresult
of this insulin insufﬁciency, there is an
increase in the concentration of glucose
in the blood (known as hyperglycemia),
as well as other metabolic abnormalities.
According to the World Health Organiza-
tion, the number of individuals with di-
abetes worldwide has increased from 30
millionin1985to171millionin2000(1);
these rates are expected to further increase,
with the World Health Organization pre-
dicting that the worldwide prevalence in
adults will reach 6.4% by 2030, corre-
sponding to a 39% increase from 2000
to 2030 (2). Of the diagnosed cases of
diabetes, it is estimated that approxi-
mately 90–95% of individuals have type
2 diabetes (3).
Type 2 diabetes is an independent
risk factor for both macrovascular disease
(e.g.,myocardialinfarctionandstroke)and
microvascular disease (e.g., retinopathy
and nephropathy), and is often associated
with other cardiovascular (CV) disease
(CVD) risk factors, including high blood
pressure (BP), dyslipidemia, obesity, lack
of physical activity, and smoking (4,5).
Although glycemic control is a key thera-
peutic target for individuals with type 2
diabetes, the major cause of morbidity
and mortality among this patient popula-
tion is CVD, not metabolic dysregulation
(6). CVD is the leading cause of mortality
among individuals with diabetes (7,8),
accounting for 65% of all deaths among
this patient group (9). Furthermore, di-
abetes is twice as common among popu-
lationsofpatientswithheartfailurewhen
compared with matched control subjects
(10), and patients with diabetes are more
likelytodevelopheartfailureafteramyo-
cardial infarction than nondiabetic indi-
viduals (11).
Exercise has long been recognized
as a cornerstone of diabetic management
and the prevention of incident diabetes.
For example, the American College of
Sports Medicine currently recommends
that individuals with type 2 diabetes
expend a minimum cumulative total of
1,000 kcal per week of energy from
physical activities (12). Meta-analyses
have shown that aerobic or resistance
training (RT) is related to statistically sig-
niﬁcant improvements in glycemic con-
trol (13–15). Support for the effect of
exercise on other CV risk factors, how-
ever, is lacking. Therefore, we conducted
thisreviewtoinvestigatetheeffectsofaer-
obic exercise, RT, and combined aerobic
a n dR To nC Vr i s kf a c t o r si nt y p e2
diabetes.
RESEARCH DESIGN AND
METHODS
Search strategy
The databases SPORTDiscus, SCOPUS,
PubMed, and CINAHL were searched
using similar search strategies focusing
on exercise interventions conducted with
individuals who were diagnosed with
type2diabetes.Thesearcheswerelimited
to studies taking place from 1970 to
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Reviews/Commentaries/ADA Statements
META-ANALYSISOctober 2009 and studies published as
full reports in the English language.
References of relevant review articles
and trials were screened to identify arti-
cles that were not found through the
database searches.
Inclusion and exclusion criteria
The study populations consisted of indi-
viduals aged $18 years who have a diag-
nosis of type 2 diabetes and are engaging
in a structured exercise program consist-
ing of aerobic exercise, progressive RT, or
combined aerobic and progressive RT.
Because we were interested in exercise
programs that had the potential to meet
the American College of Sports Medi-
cine’s recommendation that individuals
with type 2 diabetes expend a minimum
cumulativetotalof1,000kcalper weekof
energy from physical activities, forms of
exercise that did not meet this deﬁnition
(i.e., tai-chi) were not included. To be in-
cluded, the exercise intervention had to
be quantiﬁable in terms of frequency, in-
tensity, time, and duration. Only studies
whose treatment was allocated using a
randomized procedure and whose con-
trol group was not prescribed exercise as
part of the study were eligible for inclu-
sion. Because HbA1c reﬂects the average
blood glucose level during the preceding
8–12 weeks, and given that we were in-
terestedintheeffectsofsustainedexercise
as opposed to acute bouts, we only in-
cluded trials in which the exercise inter-
vention had a minimum duration of 8
weeks. Finally, we only included studies
thatmeasuredatleastoneofthefollowing
outcome measures.
Outcome measures
The chronic hyperglycemia that charac-
terizes type 2 diabetes is related to a
signiﬁcant long-term sequelae, including
damage to and eventual failure of various
organs (macrovascular), and directly re-
lated to the likelihood of developing
microvascular complications (8). There-
fore, our primary outcome measure was
HbA1c, which not only provides an esti-
mate of overall control of blood glucose
levels within the preceding 8–12 weeks
but also is considered the gold standard
formeasuring long-termglycemiccontrol
(8,16).
Our secondary outcomes included
dyslipidemia (HDL cholesterol [C] levels,
LDL-C levels, triglyceride levels), systolic
BP (SBP), BMI, waist circumference, and
weight.Althoughthereisstrongevidence
to support the notion that improved
glycemic control reduces the risks of
microvascular complications, a relation-
ship between improved glycemic control
and reduction in macrovascular complica-
tion has not been demonstrated through
randomized controlled trials (8,16).
Therefore, our secondary outcomes in-
cluded dyslipidemia, a condition that is
commonly characterized in patients with
type 2 diabetes by the “atherogenic lipid
triad” of hypertriglyceridemia, low levels
of HDL-C, and a predominance of small,
dense, LDL-C particles (17) and that has
an established relationship with risk of
macrovascular complications (8). SBP
is a marker of hypertension that has a
stronger association with risk of CVD
and renal disease than diastolic BP
(DBP) (18). Obesity is a prominent risk
factor of type 2 diabetes, with an esti-
mated 86% of individuals with type 2
diabetes being overweight or obese, of
whom 52% are obese and 8.1% are
morbidly obese (19). Moreover, obesity
is an independent risk factor for CVD
(20), and weight loss among patients
with diabetes is often associated with
reduced clinical symptoms and mortal-
ity risk (21). Therefore, our secondary
outcomes included BMI and weight
as measures of changes in body compo-
sition.
Statistical analysis
Statistical analysis was performed using
Review Manager 5 software (RevMan
5.0.17, Cochrane Collaboration, Oxford,
U.K.). For continuous outcomes pre-
sented on the same scale, we used a
weighted mean difference (WMD) calcu-
lated using the ﬁnal follow-up P values pro-
vided for the intervention and control
groupstoanalyzethesizeoftheintervention
effects. When continuous outcomes were
not presented on the same scale, standard-
ized mean differences (SMDs) were used to
analyze the size of the intervention effects
for the intervention and control groups at
the studies’ last reported end points. In the
event that study outcomes were presented
as change scores, the ﬁrst author of the
study wascontacted witha requestfor pre-
post data. Studies whose authors did not
respond within 1 month’st i m eo rw h o s e
prepost data could not be obtained from
the Cochrane Collaboration’s Library ofre-
views (13) were excluded (22,23). All data
were initially analyzed with a ﬁxed effects
model. A standard x
2 test was used to as-
sess the presence of heterogeneity between
studies,withan a signiﬁcance levelof0.05
used as an indicator of the presence of
signiﬁcant heterogeneity. The degree of in-
consistency among study results was
estimated using the I
2 parameter, where
an I
2 parameter .50% was considered
indicative of substantial heterogeneity.
Where heterogeneity was found, the anal-
ysis was redone using a random effects
model.
RESULTS—In the initial search of the
databases, 645 articles were initially iden-
tiﬁed. The most common reasons for
excluding articles were lack of a no-
exercise or standard care control group;
exercise intervention could not be quan-
tiﬁed in terms of frequency, intensity,
duration, and time; study investigating
the effects of acute exercise; wrong study
design; and irrelevant study population.
A total of 34 articles were included in the
review, with two studies (24,25) includ-
ingthreetreatmentarms(acombinedaero-
bic and RT arm, an aerobic exercise arm,
a n da nR Ta r m )a n do n es t u d y( 2 6 )i n -
cluding two treatment arms (a combined
aerobic and RT arm and an aerobic exer-
cise arm). Therefore, 21 studies (24–26,
Supplementary Refs. S1–S18) reported
outcomes on the effects of aerobic exer-
cise, eight studies looked at the effects of
RT (24,25, Supplementary Refs. S19–
S24), and 10 studies reported on the
effects of combined aerobic and RT in
type 2 diabetes (24–26, Supplementary
Refs. S25–S31). Four studies reported
results through separate publications
(Supplementary Refs. S1–S3, S12, and
S13).
Characteristics of included studies
Aerobic exercise. Themajorityofstudies
(21 studies) included investigated the
effects of aerobic exercise among patients
with type 2 diabetes (Table 1). The fre-
quency of prescribed exercise ranged
from a minimum of one to a maximum
of seven sessions per week, with 13 of the
studies prescribing exercise 3 days per
week. Exercise intensity was reported in
terms of percentage of VO2 max, VO2
peak, or maximum heart rate (HR); one
study reported exercise intensity in terms
of kilocalories expended per week. The
intensity of exercise ranged between 50
and 85% VO2 max or VO2 peak and 55
and 85% maximum HR. Length of exer-
cise sessions ranged between 40 and
75 min, and duration of exercise inter-
vention ranged between 2 months and
1 year.
RT. All eight studies looking at the effects
of RT (Table 2) involved three supervised
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Chudyk and PetrellaTable 1—Characteristics of aerobic exercise trials
Study Intervention Frequency, intensity, time, duration Adherence
Kaplan et al., 1985
(Supplementary Ref. S7)
Diet vs. exercise
(walking) vs. diet +
exercise vs. control
Exercise group: 8/10
sessions; 2 sessions
unknown
Directly supervised;
log book
F: 1 day/week
I: 60–70% VO2 max
T: 40–60 min
D: 10 weeks
Ronnemaa et al., 1986 and
1988 (lipid results for 1986
study) (Supplementary
Refs. S12 and S13)
Exercise (walking, jogging,
or skiing) vs. control
(no instructions re: exercise)
F: 5–7 sessions/week Exercise diaries
I: 70% VO2 max
T: 45 min
D: 4 months
Wing et al., 1988
(Supplementary Ref. S15)
Diet + exercise
(walking) vs. diet
F: 4 days/week
I: ;1,561 kcal/week
3/4 days supervised
for ﬁrst 10 weeks
T: 3 miles/session
D: 10 weeks
Raz et al., 1994
(Supplementary Ref. S11)
Exercise (bicycle,
treadmill, rowing
machine) vs. control
F: 3 days/week
I: 65% of VO2 max
2/3 directly supervised
sessions/week
T: 60 min
D: 12 weeks
Ligtenberg et al., 1997
(Supplementary Ref. S8)
Aerobic exercise (e.g.,
bicycle ergometer,
swimming, rowing) vs.
no exercise control
F: 3 days/week
I: 60–80% VO2 max
T: 50 min
D: 26 weeks
Supervised group exercise
ﬁrst 6 weeks, then
training at home;
log book
Mourier et al., 1997
(Supplementary Ref. S10)
Training + BCAA supplement
vs. training + placebo vs.
sedentary + BCAA supplement
vs. sedentary + placebo
Pretraining period, then:
F: 2 days/week
I: 75% of VO2 peak supervised
45-min cycling class
plus
Directly supervised
F: 1 day/week
I: 5 exercises at 85% of VO2
peak (on an ergocycle)
separated by 3 min of
exercise at 50% VO2 peak.
Both for:
D: 2 months
Boudou et al., 2001 (lipid
results) and 2003
(Supplementary Refs.
S1 and S2)
Continuous + intermittent
exercise vs. control (exercised
on ergometer at a constant rate
of 60 r.p.m. for 20 min at low
intensity [30 W])
F: 2 days/week
I: 75% of VO2 peak supervised
45-min cycling class
plus
Directly supervised
F: 1 day/week
I: 5 exercises at 85% of VO2 peak
separated by 3 min of exercise
at 50% VO2 peak.
Both for:
D: 2 months
Cuff et al., 2003 (22) Aerobic (treadmill, bicycle,
recumbent stepper, elliptical
trainer, rowing machine)
vs. combined aerobic + PRT
vs. control (usual care)
F: 3 days/week
I: 60–75% HRR
T: 75 min
D: 16 weeks
Directly supervised
1230 DIABETES CARE, VOLUME 34, MAY 2011 care.diabetesjournals.org
Exercise and cardiovascular riskTable 1—Continued
Study Intervention Frequency, intensity, time, duration Adherence
Van Rooijen et al., 2004
(Supplementary Ref. S14)
Home exercise (walking) +
hospital-based aerobics vs.
control (relaxation exercises)
Home exercise:
F: 23/day
Physical activity log;
attendance log
I: moderate RPE of 12–14
(“somewhat hard” on
Borg scale)
T: start at 10 and work up to
45 min/session
D: 12 weeks
Hospital aerobics:
F: 6 sessions
I: 55–69% max HR
(RPE 12–14)
T: 45 min
D: 6 sessions
Middlebrooke et al., 2006
(Supplementary Ref. S9)
Exercise vs. no exercise control F: 3 days/week
I: 70–80% max HR
T: 30 min
D: 6 months
2 days/week of supervised
group exercise; ﬁtted with HR
monitors to ensure correct
intensity and duration
Brassard et al., 2007
(subjects have LV
diastolic dysfunction)
(Supplementary Ref. S3)
Exercise (bicycle ergometer) vs.
control (no aerobic
exercise or RT)
F: 3 days/week
I: 60–70% VO2 max
T: 30 min
D: 12 months
Directly supervised
Kadoglou et al., 2007
(Supplementary Ref. S5)
Exercise (mainly cycling,
treadmill walking/running,
calisthenics) vs. control
(maintain habitual activities)
F: 4 days/week Directly supervised
I: 50–85% VO2 max
T: 45–60 min
D: 16 weeks
Kadoglou et al., 2007
(Supplementary Ref. S6)
Exercise (treadmill, cycling,
calisthenics) vs. control
(maintain habitual activities)
F: 4 days/week Directly supervised
I: 50–75% VO2 peak
T: 45–60 min
D: 6 months
Sigal et al., 2007 (24) Aerobic (treadmill, bicycle
ergometer) vs. RT vs.
combined vs. control
F: 3 days/week
I: start at 60%, work up to
75% max HR
T: start at 15 min, work
up to 45 min
Supervised weekly for ﬁrst
4 weeks, biweekly thereafter;
logs; identiﬁcation scanning
at gym; HR monitors
D: 22 weeks
Brun et al., 2008
(Supplementary Ref. S4)
Exercise (walking, jogging,
or gymnastics) vs. control
(routine care)
1-month educational period
(8 2-h sessions over
4 weeks): 1 h of exercise
education + 1 h of learning
to cycle at ventilator threshold
for 20–45 min.
Then:
Activity log; HR monitor
to ensure correct training
intensity
F: 2 days/week
I: at the level of the ventilatory
threshold
T: 45 min/session
D: 11 months
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Chudyk and Petrellaexercise sessionsper week,with thestudy
by Sigal et al. (24) switching to biweekly
supervised sessions after 1 month of su-
pervised training sessions. Exercise dura-
tionvariedbetweeneachinterventionand
ranged between 8 weeks and 6 months.
Exercise intensity ranged between 50 and
80% one repetition maximum among the
studies.
Combined aerobic and RT. Ten studies
were selected for inclusion within this
exercise category (Table 3). The majority
ofthestudiesdirectlymonitoredthecom-
pliance of the subjects with the exercise
protocol for at least one session per week,
with one study switching to biweekly su-
pervised exercise sessions after 1 month
of training and one study relying on ac-
tivitylogstomonitorpatientadherenceto
the exercise protocol. Six of the studies
involved an exercise program carried
out three times per week, two studies in-
volved two weekly sessions, one study in-
volved four weekly sessions, and one
study involved a goal of participants en-
gaging in exercise 5 days per week. Inten-
sity of the prescribed aerobic exercise
varied between an initial exercise inten-
sity of 35% HR maximum to an upward
maximum of 85% HR max. The resis-
tance component of the interventions
varied in terms of prescribed load, repe-
tition, and number of sets. Duration of
the interventions ranged between 8 weeks
and 24 months, with nine of the ten
studies having a duration of at least 3
months.
Outcomes
HbA1c. Aerobic exercise reduced HbA1c
by 0.6% (20.62 HbA1c WMD, 95% CI 2
0.98 to 20.27). RT alone was not found
to have a statistically signiﬁcant effect
on HbA1c (20.33 HbA1c WMD, 95% CI
20.72to 0.05).Combinedaerobicand RT
reduced HbA1c by 0.67% (20.67 HbA1c
WMD, 95% CI 20.93 to 20.40), which
is considered both statistically and clini-
cally signiﬁcant.
Dyslipidemia. Aerobic exercise was not
fou ndtoh aveasig niﬁcant effect on HDL-
C( 20 HDL WMD, 95% CI 20.05 to
0.05) and LDL-C (20.10 WMD, 95% CI
20.44 to 0.24). However, aerobic exer-
cise was related to a 0.3 mmol/L decrease
(20.29 WMD, 95% CI 20.48 to 20.11)
in triglycerides. Estimates of the effects of
RT on HDL-C and LDL-C were not made
because only two studies investigated
these outcomes. Because only Sigal et al.
(24) investigated the effects of RT on tri-
glyceride levels, a summary of effect was
not calculated for this outcome. Com-
bined aerobic and RT was not found to
h a v eas i g n i ﬁcant effect on HDL-C (0.05
HDL-C WMD, 95% CI 20.05 to 0.15)
and LDL-C (20.07 LDL-C WMD, 95%
CI 20.25 to 0.11), but lowered triglycer-
ides by 0.3 mmol/L (20.30 triglycerides
WMD, 95% CI 20.57 to 20.02). The
number of trials in this analysis was
small.
Body composition. Nostatistically signif-
icant relationships were found between
anyoftheexercisecategoriesandchanges
in BMI or body mass; because only one
RT study reported BMI as an outcome,
estimatesofeffectwerenotcalculatedfor
BMI within this exercise category. Aero-
bic exercise was not related to changes
in BMI (20.33 BMI WMD, 95% CI
21.26 to 0.61) or body mass (0.16
body mass WMD, 95% CI 23.43 to
3.76). RT was not related to changes in
body mass (20.48 body mass WMD,
95% CI 24.98 to 4.02). Combined aer-
obic and RT was not related to changes
inBMI (20.78 BMI WMD, 95% CI 21.89
to 0.33) or body mass (21.02 body mass
WMD, 95% CI 22.85 to 0.82). However,
waist circumference did show improve-
ment (23.1 cm) after combined aerobic
and RT (23.1 WMD, 95% CI 210.3 to
21.2). This difference was signiﬁcant.
SBP. Aerobic exercise was related to a
decrease in SBP of 6 mmHg (26.08
WMD, 95% CI 210.79 to 21.36). This
decrease was found to be statistically
signiﬁcant, but there was signiﬁcant
heterogeneity present. RT was not re-
lated to a statistically signiﬁcant change
in SBP among patients with type 2 dia-
betes (24.36 WMD, 95% CI 212.14 to
3.42). Combined aerobic and RT is re-
lated to a decrease in SBP of 3.59 mmHg
Table 1—Continued
Study Intervention Frequency, intensity, time, duration Adherence
Lambers et al., 2008 (26) Combined endurance +
strength training (circuit)
vs. endurance (similar to
circuit—same intensity
but no strength training
exercises) vs. control
F: 3 days/week Directly supervised
I: 60–85% max HR; RT: started at
60%, increased to 85% 1 RM,
3s e t so f1 0 –15 reps
T: 60 min/session
D: 3 months
Nojima et al., 2008
(Supplementary Ref. S17)
Aerobic training (suggested
walking, jogging, cycling,
swimming) vs. control
(routine care)
F: at least 3 days/week Not assessed
I: not stated
T: at least 30 min/session
D: 12 months
Wycherley et al., 2008
(Supplementary Ref. S18)
Aerobic training (walking/
jogging) + caloric
restriction vs. caloric
restriction
F: 4–5d a y s / w e e k
I: 60–65% HR max increased
to 75–80% HR max by
week 12
T: 25–30 min/session increased
to 55–60 min/session by
week 12
D: 12 weeks
HR monitors; at least
1 directly supervised
session/week
BCAA, branched-chain amino acid; D, duration; F, frequency; HRR, heart rate reserve; I, intensity; LV, left ventricular; PRT, progressive resistance training; reps,
repetitions; RM, repetition maximum; RPE, rating of perceived exertion; T, time.
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Exercise and cardiovascular risk(23.59 WMD, 95% CI 26.93 to 20.24).
This decrease was statistically signiﬁcant.
CONCLUSIONS—Management of CV
risk factors is a priority among individuals
with type 2 diabetes, because CVD is the
leading cause of death among individuals
withdiabetes(8).Furthermore,individuals
withtype2diabetesareatanincreasedrisk
ofmicrovascular complications.According
to the 2008 Canadian Diabetes Associa-
tion guidelines, the main interventions
forreducingrisk ofCVDincludecontrol-
ling blood glucose and blood lipid levels,
as well as controlling BP (8). Therefore,
Table 2—Characteristics of RT trials
Study Intervention Frequency, intensity, time, duration Adherence
Dunstan et al., 1998
(Supplementary Ref. S22)
RT vs. no exercise
control
F: 3 days/week Directly supervised
I: 50–55% of 1 RM
T: 3 sets of 10–15 reps
(2 sets only for ﬁrst 2 weeks)
D: 8 weeks
Castaneda et al., 2002
(Supplementary Ref. S21)
RT vs. nontraining
control
F: 3 days/week Directly supervised
I: 60–80% of 1 RM progressing
to 70–80%
of midstudy 1 RM
T: 3 sets of 8–10 reps
D: 16 weeks
Dunstan et al., 2002
(Supplementary Ref. S23)
Moderate weight loss +
supervised high-intensity
RT vs. moderate weight
loss + control
F: 3 days/week Directly supervised
I: 50–60% of 1 RM progressing
to 75–85% of 1 RM
T: 3 sets of 8–10 reps
D: 6 months
Baldi et al., 2003
(Supplementary Ref. S19)
Moderate intensity RT
vs. nontraining control
F: 3 days/week Directly supervised
I: max weight at which
subject could complete
10 upper and 15 lower
body sets; increased by
5% when subject
completed prescribed
circuits and reps
T: 2 sets of 12 reps
(1 set only for ﬁrst week)
D: 10 weeks
Brooks et al., 2007
(Supplementary Ref. S20)
RT vs. nontraining control F: 3 days/week Directly supervised
I: 60–80% of 1 RM for
8w e e k s ,t h e n7 0 –80%
of midstudy 1 RM
T: 3 sets of 8 reps
D: 16 weeks
Sigal et al., 2007 (24) RT vs. control F: 3 days/week
I: max weight at which
“T” can be done
T: 2–3s e t so f7 –9r e p s
Supervised weekly for ﬁrst 4
weeks, biweekly thereafter;
logs; identiﬁcation scanning
at gym; HR monitors
D: 22 weeks
Cheung et al., 2009
(Supplementary Ref. S24)
RT vs. routine care F: 5 days/week + 2 supervised
sessions 1st month then 1
supervised session each month
Diary
I: increased tension of band
when 12 reps performed with
good form
T: 2 sets of 12 reps
D: 16 weeks
D, duration; F, frequency; I, intensity; reps, repetitions; RM, repetition maximum; RPE, rating of perceived exertion; T, time.
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Study Intervention Frequency, intensity, time, duration Adherence
Tessier et al., 2000
(Supplementary Ref. S30)
Mixed aerobic (rapid walking) +
RT (2 sets of 20 reps of
major muscle groups)
F: 33/week Directly supervised
I: 35–59% HR max progressing
to 60–79% HR max at week 4
until the end of the study;
2s e t so f2 0r e p s
T: 60 min (20 aerobic, 20 RT)
D: 16 weeks
Maiorana et al., 2002
(Supplementary Ref. S29)
Circuit training (7 RT +
8 aerobic exercises)
vs. control
F: 3 days/week Directly supervised
I: 55% pretraining MVC to 65%
by week 4 (RT); 70% peak
baseline HR – 85% by week
6( a e r o b i c )
T: 60 min
D: 8 weeks
Work:rest 45:15 s
Cuff et al., 2003 (22) Combined aerobic (treadmill,
bicycle, recumbent stepper,
elliptical trainer, rowing
machine) + PRT (5
exercises of major muscle
groups) vs. control
(usual care)
F: 3 days/week Directly supervised
I: 60–75% HRR; 2 sets of 12 reps
T: 75 min
D: 16 weeks
Loimaala et al., 2003
(Supplementary Ref. S27)
Circuit training (8 exercises
for upper and lower
extremities) vs. no exercise
control
F: 2 days/week
I: 70–80% max voluntary
One supervised
session/week
contraction for 10–12 reps;
65–75% VO2 max
T: minimum 30 min at target HR
D: 12 months
Balducci et al., 2004
(Supplementary Ref. S25)
Aerobic exercise (treadmill,
bicycle, or elliptical) + RT
(6 exercises for major muscle
groups) vs. standard
care control
F: 3 days/week Directly supervised
I: 40–80% HR reserve (aerobic);
3s e t so f1 2r e p s( R T )a t
40–60% 1 RM (retested
every 3 weeks)
T: 30 min aerobic + 30 min RT
D: 12 months
Loimaala et al., 2007
(Supplementary Ref. S28)
Exercise (jogging or walking +
RT) vs. control
F: 2 days/week
I: 65–75% VO2 max
T: minimum 30 min at target
HR or intensity
Two (of four) supervised
sessions/week; exercise
diary; exercise HR and
intensity controlled
D: 12 months
RT:
F: 2 days/week
I: 70–80% 1 RM
T: Three sets of 10–12 reps
D: 12 months
Sigal et al., 2007 (24) Aerobic exercise (treadmill,
bicycle ergometer) +
RT vs. control
F: 3 days/week
I: start at 60, work up to
75% max HR
T: start at 15 min, work
up to 45 min
Supervised weekly for ﬁrst 4
weeks, biweekly thereafter;
logs; identiﬁcation scanning
at gym; HR monitors
D: 22 weeks
RT:
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Exercise and cardiovascular riskweselectedouroutcomemeasuresinthis
review on the basis of these modiﬁable
risk factors for CVD.
For each 1% increase in the level of
HbA1c, the relative risk of CVD increases
by1.18%(27),whereaseach1%decrease
in HbA1c levels is associated with a 37%
reductioninmicrovascularcomplications
and a 14% reduction in myocardial in-
farctions (28). Further, lowering HbA1c
in patients with type 2 diabetes decreases
the absolute risk of developing coronary
heart disease by 5–17% and all cause
mortality by 6–15% (29). Because the re-
lationship between the risk of CVD and
death from CV causes is linear (28), we
can extend our ﬁndings of the effects of
exercise on HbA1c levels to the associated
reductions in CVD risk. The 0.67% re-
duction in HbA1c levels associated with
combined aerobic and RT is related to a
26% decrease in risk of microvascular
complications and a 10% decrease in
rate of myocardial infarctions. Similarly,
the 0.6% decrease in HbA1c levels related
to involvement in aerobic exercise is as-
sociatedwitha22%decreaseinmicrovas-
cular complications risk and an 8%
reduction in myocardial infarction rate.
These effects are comparable to that of
drug monotherapy, which is related to a
0.5–1.5% decrease in HbA1c, depending
on the pharmaceutical agent used and the
baseline HbA1c level of the individual
(30). Because the extent of HbA1c reduc-
tion is positively related to the baseline
value of HbA1c, combined aerobic and
strength training, as well as aerobic train-
ing, may be the preferred ﬁrst-line treat-
ment option for individuals with lower
baseline HbA1c values who want to delay
the onset of pharmaceutical treatment.
Future studies should also consider the
impact of concomitant use of nonphar-
macologicanddrugtherapyonCVcauses
of type 2 diabetes.
According to the Canadian Diabetes
Association, BP treatment targets for in-
dividuals with type 2 diabetes include
maintenance of SBP ,130 mmHg (8).
Both aerobic and combined aerobic and
RT exercise were related to statistically
signiﬁcant declines in SBP (6 mmHg and
3.59 mmHg, respectively). Moreover, the
mean SBP of the aerobic exercise trials
ranged between 126 and 133 mmHg at
last follow-up (mean SBP = 130 mmHg),
whereas the mean SBP of the combined
aerobic and RT ranged between 129 and
138 mmHg (mean SBP = 134 mmHg) at
last follow-up. Therefore, aerobic and
combined aerobic and RT exercise have
the potential to have a clinically signiﬁ-
cant impact on the presence of hyperten-
sion among individuals with type 2
diabetes. Both combined aerobic and
RT,aswellasaerobicexercise,werefound
to decrease triglyceride levels by 0.3
mmol/L. However, we did not ﬁnd statis-
tical support for the existence of a rela-
tionship between aerobic or RT and
improved HDL-C and LDL-C among in-
dividuals with type 2 diabetes. In a ran-
domized controlled trial of the effects
of aerobic exercise on lipid levels in
overweight individuals with mild-to-
moderate dyslipidemia, it was found
that improvements in lipid levels were
more closely associated with exercise
quantity than exercise intensity or im-
provements in ﬁtness (31). Therefore,
perhaps exercise interventions prescrib-
ing higher levels of exercise quantity
need to be carried out to positively affect
lipid levels in individuals with type 2
diabetes.
Our meta-analysis found little sup-
port for the beneﬁts of RT on CV risk
factors in type 2 diabetes. The energy
expenditure of RT is affected by the
number of sets and repetitions, rest in-
terval, number of repetitions, velocity of
movement, and load involved in the
workout (32). Moreover, the energy ex-
penditureofRTexercisesalsodependson
the combinations of muscle groups
worked (e.g., exercises involving greater
muscle mass are associated with signiﬁ-
cantly larger energy expenditure) (33).
Therefore, perhaps the RT interventions
included in this analysis were not con-
ducted at an intensity high enough to elicit
meaningful increases in energy expendi-
ture. Bloomer (34) carried out a random-
ized cross-over trial involving 10 healthy
men to compare the energy expenditure
and physiologic responses to moderate-
duration resistance versus aerobic ex-
ercise. They found that despite being
matched for total time and relative inten-
sity, the energy cost of continuous aerobic
Table 3—Continued
Study Intervention Frequency, intensity, time, duration Adherence
F: 3 days/week
I: max weight at which
“T” can be done
T: 2–3s e t so f7 –9 reps
D: 22 weeks
Krousel-Wood et al., 2008
(Supplementary Ref. S26)
Exercise tapes (combined
aerobic + PRT) vs. no
exercise control
F: goal of 5 days/week Activity logs
I: 3–6 METs while using tape
T: 10-, 20-, and 30-min tapes
D: 3 months
Lambers et al., 2008 (28) Circuit training (combined
endurance + RT)
vs. control
F: 3 days/week Directly supervised
I: 60–85% max HR;
RT: started at 60%, increased
to 85% 1 RM, 3 sets of
10–15 reps
T: 60 min
D: 3 months
D, duration; F, frequency; HRR, heart rate reserve; I, intensity; max, maximum; METs, metabolic equivalents; MVC, maximum voluntary contraction; PRT,
progressive resistance training; reps, repetitions; RM, repetition maximum; T, time.
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tentresistanceexercise(34).Therefore,fu-
ture studies on the effect of RT in type 2
diabetes should investigate the effects of
high-repetition, high-set weight lifting,
which is carried out at higher aerobic lev-
els than the more traditional power-lifting
approach. When designing future aerobic
exercise interventions, endurance exer-
c i s e ss h o u l db ep r e s c r i b e di nt e r m so f
VO2 reserve, not VO2 max, because VO2
reserve has been established as being
directly related to other relative (HR
reserve, HR max, the Borg rating of Per-
c e i v e dE x e r t i o n6 –20 scale) and absolute
(metabolic equivalents) classiﬁcations of
exercise intensity (35). Further, future
studies could identify individual meta-
bolic targets, such as the maximal level
of lipid oxidation during exercise. This
in turn would allow future meta-analysts
tomoreaccuratelycompare the effects of
different intensity levels of exercise on
outcomes of interest.
CombinedaerobicexerciseandRT,as
well as aerobic exercise carried out on its
own, taking place at least two times per
week at an intensity of 60–85% of an in-
dividual’s HR maximum, is related to sta-
tistically signiﬁcant declines in HbA1c,
triglyceride levels, waist circumference,
and SBP among individuals with type 2
diabetes; however, these exercise ap-
proaches are not related to signiﬁcant
changes in weight or BMI, or to statisti-
cally signiﬁcant changes in HDL-C and
LDL-C levels. When RT is not combined
with other forms of exercise, it is not sig-
niﬁcantlyrelatedtochangesinHbA1clev-
els or to changes in SBP. More research
needs to be conducted before the effects
of RT on HDL-C, LDL-C, and triglyceride
levels can be discerned.
Additional reference sources can be
found in the Supplementary Data.
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